Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis
Abstract Background Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains diverging reports on the effect of parathyroid hormone (PTH) on BMSC diffe...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-07-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13287-020-01820-6 |
| _version_ | 1819297783270604800 |
|---|---|
| author | Ena Music Kathryn Futrega James S. Palmer Mackenzie Kinney Bill Lott Travis J. Klein Michael R. Doran |
| author_facet | Ena Music Kathryn Futrega James S. Palmer Mackenzie Kinney Bill Lott Travis J. Klein Michael R. Doran |
| author_sort | Ena Music |
| collection | DOAJ |
| description | Abstract Background Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains diverging reports on the effect of parathyroid hormone (PTH) on BMSC differentiation. Cartilage tissue models can be heterogeneous, confounding efforts to improve media formulations. Methods Herein, we use a novel microwell platform (the Microwell-mesh) to manufacture hundreds of small-diameter homogeneous micro-pellets and use this high-resolution assay to quantify the influence of constant or intermittent PTH(1–34) medium supplementation on BMSC chondrogenesis and hypertrophy. Micro-pellets were manufactured from 5000 BMSC each and cultured in standard chondrogenic media supplemented with (1) no PTH, (2) intermittent PTH, or (3) constant PTH. Results Relative to control chondrogenic cultures, BMSC micro-pellets exposed to intermittent PTH had reduced hypertrophic gene expression following 1 week of culture, but this was accompanied by a loss in chondrogenesis by the second week of culture. Constant PTH treatment was detrimental to chondrogenic culture. Conclusions This study provides further clarity on the role of PTH on chondrogenic differentiation in vitro and suggests that while PTH may mitigate BMSC hypertrophy, it does so at the expense of chondrogenesis. |
| first_indexed | 2024-12-24T05:19:29Z |
| format | Article |
| id | doaj.art-34cbe063714c43878ca169d4e8663c07 |
| institution | Directory Open Access Journal |
| issn | 1757-6512 |
| language | English |
| last_indexed | 2024-12-24T05:19:29Z |
| publishDate | 2020-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Stem Cell Research & Therapy |
| spelling | doaj.art-34cbe063714c43878ca169d4e8663c072022-12-21T17:13:29ZengBMCStem Cell Research & Therapy1757-65122020-07-0111111010.1186/s13287-020-01820-6Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesisEna Music0Kathryn Futrega1James S. Palmer2Mackenzie Kinney3Bill Lott4Travis J. Klein5Michael R. Doran6School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT)Centre for Biomedical Technologies, Queensland University of Technology (QUT)School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT)School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT)School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT)Centre for Biomedical Technologies, Queensland University of Technology (QUT)School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT)Abstract Background Bone marrow stromal cells (BMSC) have promise in cartilage tissue engineering, but for their potential to be fully realised, the propensity to undergo hypertrophy must be mitigated. The literature contains diverging reports on the effect of parathyroid hormone (PTH) on BMSC differentiation. Cartilage tissue models can be heterogeneous, confounding efforts to improve media formulations. Methods Herein, we use a novel microwell platform (the Microwell-mesh) to manufacture hundreds of small-diameter homogeneous micro-pellets and use this high-resolution assay to quantify the influence of constant or intermittent PTH(1–34) medium supplementation on BMSC chondrogenesis and hypertrophy. Micro-pellets were manufactured from 5000 BMSC each and cultured in standard chondrogenic media supplemented with (1) no PTH, (2) intermittent PTH, or (3) constant PTH. Results Relative to control chondrogenic cultures, BMSC micro-pellets exposed to intermittent PTH had reduced hypertrophic gene expression following 1 week of culture, but this was accompanied by a loss in chondrogenesis by the second week of culture. Constant PTH treatment was detrimental to chondrogenic culture. Conclusions This study provides further clarity on the role of PTH on chondrogenic differentiation in vitro and suggests that while PTH may mitigate BMSC hypertrophy, it does so at the expense of chondrogenesis.http://link.springer.com/article/10.1186/s13287-020-01820-6Mesenchymal stem cellChondrogenesisHypertrophyParathyroid hormoneMicrowell |
| spellingShingle | Ena Music Kathryn Futrega James S. Palmer Mackenzie Kinney Bill Lott Travis J. Klein Michael R. Doran Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis Stem Cell Research & Therapy Mesenchymal stem cell Chondrogenesis Hypertrophy Parathyroid hormone Microwell |
| title | Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis |
| title_full | Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis |
| title_fullStr | Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis |
| title_full_unstemmed | Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis |
| title_short | Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis |
| title_sort | intermittent parathyroid hormone 1 34 supplementation of bone marrow stromal cell cultures may inhibit hypertrophy but at the expense of chondrogenesis |
| topic | Mesenchymal stem cell Chondrogenesis Hypertrophy Parathyroid hormone Microwell |
| url | http://link.springer.com/article/10.1186/s13287-020-01820-6 |
| work_keys_str_mv | AT enamusic intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT kathrynfutrega intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT jamesspalmer intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT mackenziekinney intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT billlott intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT travisjklein intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis AT michaelrdoran intermittentparathyroidhormone134supplementationofbonemarrowstromalcellculturesmayinhibithypertrophybutattheexpenseofchondrogenesis |